The FDA upgraded the recall of Vitruvias Therapeutics 30 mg thyroid tablets to Class I due to potential superpotencyHealthSep 24 at 10:30 AM – Sep 24 at 4:04 PM3 outletsUnited StatesQuartzFDA upgraded a recalled thyroid tablet to its most dangerous recall category Sep 24 at 10:30 AMKING 5Thyroid medication recall upgraded to FDA's highest risk level Sep 24 at 11:19 AMWCVBThyroid medication recall elevated to FDA's highest risk level seen Sep 24 at 4:04 PM